Business
Coherus BioSciences to Report First Quarter 2021 Financial Results on May 6th
REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that its first
About this update from Coherus Oncology, Inc.
[{"type":"text","content":"REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that its first quarter 2021 financial results will be released after market close on Thursday, May 6, 2021. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. After releasing first quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com. Conference Call Information When: Thursday, May 6, 2021 starting at 4:30 p.m. ETDial-in: (800) 446-2782 (Toll-Free U.S. and Canada) or (847) 413-3235 (International)Conference ID: 50149707Webcast: https://investors.coherus.com/upcoming-events Please dial-in 15 minutes early to ensure a timely connection to the call. About Coherus BioSciencesCoherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com. Coherus BioSciences Contact Information:Investor Contact:McDavid Stilwell, CFOCoherus BioSciences, [email protected] \nSource: Coherus BioSciences, Inc.","length":3046,"tagName":"div"}]